That these phenomena are clinically relevant is supported by studies showing the presence of cells expressing both VSMC and macrophage markers in human atherosclerotic plaques 8 and by the recent demonstration that from 30% to 40% of cells positive for the macrophage marker CD68 in human plaques are likely to be of VSMC origin. 16 Despite these provocative Objective-We previously showed that cholesterol loading in vitro converts mouse aortic vascular smooth muscle cells (VSMC) from a contractile state to one resembling macrophages. In human and mouse atherosclerotic plaques, it has become appreciated that ≈40% of cells classified as macrophages by histological markers may be of VSMC origin. Therefore, we sought to gain insight into the molecular regulation of this clinically relevant process. Approach and Results-VSMC of mouse (or human) origin were incubated with cyclodextrin-cholesterol complexes for 72 hours, at which time the expression at the protein and mRNA levels of contractile-related proteins was reduced and of macrophage markers increased. Concurrent was downregulation of miR-143/145, which positively regulate the master VSMC differentiation transcription factor myocardin. Mechanisms were further probed in mouse VSMC. Maintaining the expression of myocardin or miR-143/145 prevented and reversed phenotypic changes caused by cholesterol loading.
T he hallmark of atherosclerotic plaque development is the accumulation in the arterial wall of cholesterol-engorged macrophage foam cells. [1] [2] [3] [4] [5] It has been generally accepted that the majority of plaque macrophages originate from circulating monocytes. Like intimal macrophages, vascular smooth muscle cells (VSMC) have also been shown to accumulate excess cholesterol, contributing to atherosclerosis development and progression. 6 . Formation of lipid-laden VSMC has been documented in both in vivo [7] [8] [9] and in vitro studies. [10] [11] [12] [13] [14] In previous studies, we demonstrated that mouse aortic VSMC that were loaded with cholesterol assumed the appearance of macrophage foam cells, and we raised the intriguing possibility that foam cells in the plaque presumed to be macrophages may instead be of VSMC origin. 15 After cholesterol loading, VSMC showed a marked decline in the expression of genes specifically related to the contractile phenotype (eg, SM α-actin), whereas expression of macrophage markers (eg, CD68) was increased at both the protein and the mRNA levels.
findings, the molecular mechanisms underlying this transition remain poorly defined. Furthermore, whether these CD68positive VSMC can support macrophage functions known to influence atherogenesis, such as innate immune signaling, phagocytosis, and efferocytosis, is not known.
To address these outstanding questions, we have applied unbiased transcriptome-and transcription factor-binding site motif enrichment analyses to identify important molecular regulators of mouse VSMC phenotypic variation after cholesterol loading. In addition, using a global transcriptional data analysis algorithm (principal component analysis [PCA]), we determined the relationship between the cholesterol-induced CD68 + VSMC phenotype and that of authentic macrophages. These analyses pointed to multiple and independent pathways by which cholesterol loading suppresses the expression of the master regulator of the contractile state of VSMC, the transcription factor myocardin , and its coactivator, serum response factor (SRF). 17 Notably, despite gaining several macrophage features, the molecular profile of the cells remained substantially that of VSMC, consistent with their poor activity relative to macrophages in functional assays. Furthermore, many effects of cholesterol loading on the VSMC phenotype were largely reversible by the promotion of cholesterol efflux by high-density lipoprotein (HDL) and other acceptors.
Similar to the plasticity of monocyte-derived macrophages in inflammatory sites, 18 then, VSMC in atherosclerotic plaques are also in dynamic phenotypic states, traditionally categorized as constitutive (or contractile) and synthetic, 19 altering their morphological and functional features depending on factors in their microenvironment. Collectively, our present data, taken with the findings in vivo by us and others 16, 20 suggest that in atherosclerotic plaques, one such factor is cholesterol, which causes the development of a third phenotypic state that superficially resembles macrophages.
Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Cholesterol Loading Converts Mouse Aortic VSMC to a Macrophage Foam Cell-Like State
In contrast to mouse aortic VSMC incubated with 0.2% BSA, those incubated for 3 days with cyclodextrin-cholesterol complexes became foam cells, as evidenced by the appearance of Oil-Red-O-stained lipid droplets ( Figure 1A ). Cholesterol-loaded cells also showed a significant decrease in the protein expression of the VSMC marker, SM α-actin (ACTA2), whereas that of macrophage-related marker, CD68, increased ( Figure 1B) . In contrast, BSA-incubated cells stained heavily with antibodies to ACTA2, but not to CD68 ( Figure 1B ). To characterize the phenotypic changes further, we performed quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) assays. Cholesterol loading led to dramatic decreases in mRNA levels for VSMC-related genes Acta2, α-tropomyosin (Tpm1), SM myosin heavy chain (Myh11), and calponin (Cnn1), whereas those for the macrophage markers, CD68 (Cd68) and Mac-2 (Lgals3), and the cholesterol efflux factor, Abca1, increased ( Figure 1C and 1D). Similar findings were found with human coronary artery SM cells ( Figure I in the online-only Data Supplement). These results are consistent with what we have previously reported, 15 and finding them in 2 species supports the general importance and clinical relevance of the findings, as well as the undertaking of the series of experiments to be described.
Transcriptome Profiling Reveals Multiple Changes Associated With Cholesterol Loading of VSMC
To identify key molecular mechanisms regulating VSMC phenotypic changes in vitro, RNA samples from control-and cholesterol-treated VSMC were used for transcriptome profiling. The analysis revealed 613 genes for which differential probeset intensities were detected between the 2 sample groups (Materials and Methods and Table II in the online-only Data Supplement). Of these, 270 genes were detected at higher mRNA levels in the cholesterol versus control-treated VSMC and 343 genes were detected at lower levels. Heatmaps from the microarray analysis are shown in Figure 2A . Consistent with the qRT-PCR data in Figure 1 , the transcriptome profiling detected (all P<0.01) cholesterol-loading upregulation of macrophage markers Cd68 (2.9-fold) and Lgals3 (2.8-fold) and cholesterol transporters Abca1 (6.4-fold) and Abcg1 (8.3fold), but downregulation of VSMC markers Cnn1 (15-fold), Actg2 (6.5-fold), and Tpm1 (1.6-fold). Cholesterol loading also upregulated several macrophage-specific inflammatory cytokine mRNAs, including Ccl2 (15.8-fold) and Ccl7 (56-fold), as well as the toll-like receptor Tlr4 (1.9-fold), which initiates proinflammatory responses to microbial and endogenous ligands. qRT-PCR results for selected genes identified on the microarray as significantly increased in expression are shown in Figure II in the online-only Data Supplement. These results not only further validate the trends observed on the array but also by comparing them with qRT-PCR results with RNA isolated from bone marrow-derived macrophages ( Figure III in the online-only Data Supplement), they show that cholesterol loading was a stronger relative influence on inflammation-related gene expression in VSMC. Additional qRT-PCR results showed that for some genes whose products have been associated with plaque rupture and thrombosis (Mmp2, Mmp9, Mmp13, F3 [tissue factor]), only that of Mmp13 was significantly increased in cholesterol-load VSMC (H. Nishi, E. Fisher, data not shown).
PCA of the Transcriptome Profiles Characterizes the Relationship Between Cholesterol-Loaded VSMC and Authentic Macrophages
The microarray results, taken with those in Figure 1 , suggest that cholesterol-loaded VSMC assume some characteristics of macrophages, including inflammatory features. Thus, we wondered how globally similar they were to authentic macrophages and another monocyte-derived cell found in mouse and in human plaques, dendritic cells. For this, PCA was performed on the microarray data and on published array results for macrophages, monocytes, and dendritic cells. PCA is a statistical technique for determining the key variables in a multidimensional data set that explain the differences in the observations and can be used to simplify the analysis and visualization of multidimensional data sets. PCA is often applied to microarray expression data to summarize the ways in which gene responses vary under different conditions 21 (Materials and Methods in the online-only Data Supplement).
In the graph in Figure 2B , each data mark represents 1 of the 31 microarray hybridizations. The scatter plot of the 2969 most variable probesets across the combined data set ( Figure 2B ) shows the loading values for each microarray study for principal components 1 and 2. The 2 solid circle marks show the centroid of the loading values, for principal components 1 and 2 (ie, PC1 and PC2; Materials and Methods in the online-only Data Supplement) for the hematopoietic (magenta) and VSMC (red) hybridizations, respectively. The distance between the 2 centroids, 0.54, is greater than the average spread between the hematopoietic cell types (0.34), suggesting that cholesterol-loaded VSMC in vitro remain distinguishable from the hematopoietic cells, despite acquiring a foam cell appearance and some features of macrophages, while losing expression of commonly accepted markers of VSMC phenotype. Consistent with this are qRT-PCR results that show that the absolute mRNA levels of macrophage-associated factors Cd68 and Lgals3 in cholesterol-loaded VSMC are at most 20% of those in bone marrow-derived macrophages (H. Nishi, E. Fisher, data not shown).
To characterize cholesterol-loaded VSMC further, we compared their gene expression profiles and transcriptional regulators to the core signature of mature tissue macrophages from various mouse organs identified by Gautier et al. 22 Of the 37 macrophage signature genes in the study, only 15 were upregulated in cholesterol-loaded VSMC, as shown in Figure IV in the online-only Data Supplement. Notably, 2 key marker genes, Mertk and Fcgr1 (CD64), universally associated with mature tissue macrophages, were not upregulated by cholesterol loading.
Functional Properties of Cholesterol-Loaded VSMC Relative to Those of Macrophages
To test whether mouse VSMC converted to macrophage-like cells on cholesterol loading become competent macrophages, we tested their ability to perform key macrophage functions. We incubated control VSMC, cholesterol-loaded VSMC, and mouse peritoneal macrophages with 1-µm latex beads for 24 hours and compared the phagocytic activities. As shown in Figure 2C (representative images in Figure V in the onlineonly Data Supplement), latex bead accumulation was significantly increased (6.3±0.6 beads/cell) in cholesterol-loaded VSMC versus control VSMC (1.1±0.18 beads/cell). This was modest phagocytic activity, however, compared with that of peritoneal macrophages (25.5±0.4 per cell). Because the related activity of efferocytosis of apoptotic macrophages in Figure 1 were used for DNA microarray analyses (Materials and Methods in the online-only Data Supplement). A, Heatmap colorations indicating differential mRNA expression of genes (rows) in each of the samples (columns; n=2 for each sample group) with respect to the average expression in the control sample group (red=higher expression than the control group average, green=lower). The heatmap shows upregulation of macrophage-and cholesterol efflux-related genes and downregulation of VSMC-related genes and Hmgcr (encoding the rate-limiting enzyme in cholesterol biosynthesis). B, Comparison of cholesterol-loaded VSMC and macrophages using principal components analysis (PCA; see Materials and Methods in the online-only Data Supplement for an explanation of PCA) of the microarray data, which shows that cholesterolloaded VSMC are distinct from hematopoietic cells. Each data mark represents 1 of 31 microarray hybridizations, taken from 5 different studies. C, Control, cholesterol-loaded VSMC, and peritoneal macrophages were incubated with 1 µ latex beads (green). The beads inside the cells were counted to quantify phagocytotic activity. Data shown are mean±SD and are representative of 2 independent experiments. D, Efferocytosis activity was measured by exposing VSMC or bone marrow-derived macrophage (BMDM) for 2 hours to dead Jurkat cells that had been prelabeled with Cell Tracker Orange. After washing away noninternalized Jurkat cells, the internalized ones were visualized by fluorescent microscopy (middle). After fixation, VSMC and BMDM were also stained for actin by phalloidin (left). DC indicates dendritic cell; Mφ, macrophages; PC1/2, principal components 1 and 2; pDC, plasmacytoid dendritic cell; SMC, smooth muscle cell; SRF, serum response factor; and TLR, toll-like receptor.
plaques is crucial for limiting the dispersal of lipid and inflammatory substances from the deteriorating cells, 23 we wondered whether the latex bead results presaged a similar deficiency of efferocytosis by cholesterol-loaded VSMC. As shown in Figure 2D , indeed this was the case. Not only was the activity relative to bone marrow-derived macrophages ≈25% but also was not noticeably increased by cholesterol loading in either cell type ( Figure VI in the online-only Data Supplement). These results suggest that in spite of their immunohistological appearance as macrophages in vitro 15 (Figure 1 ) and in vivo, 8, 16, 20 cholesterol-loaded VSMC are relatively deficient in phagocytosis and efferocytosis.
Macrophage Marker Positive Cells of VSMC Origin Are Located Near Necrotic Cores in Mouse Atherosclerotic Plaques
The functional assays suggested that in atherosclerotic plaques, cholesterol-loaded VSMC may contribute to the pathology because efferocytosis, as alluded to above, regulates the clearance of apoptotic cells and its deficiency expands the necrotic core and retards inflammation resolution in experimental atherosclerosis. 23 Using lineage-tracing techniques, the laboratories of Gary Owens and Robert Feil have found macrophage-like cells of VSMC origin in Apoe −/− mouse atheromas. 20, 24 To determine this using a nonlineage tracing technique, we first examined the microarray data to define VSMC markers that did not change after cholesterol loading. Caldesmon (CALD1), a calmodulin-binding protein, 25 is barely detectable in monocyte-derived CD68 + cells in mouse atherosclerotic plaques, 26 but it is strongly expressed in VSMC independent of cholesterol loading.
We then performed double immunostaining with anti-CD68 and anti-CALD1 antibodies on plaque sections from Apoe −/− mice kept 16 weeks on Western diet. As shown in Figure VIIA in the online-only Data Supplement, in the plaques, there were (red) CALD1 + VSMC in the media or in the fibrous caps and (green) CD68 + macrophages. Notably, we also identified a subset of double-stained (yellow) cells expressing both markers ( Figure VIIB in the online-only Data Supplement, arrows). We then used Oil-Red-O to enhance foam cell and necrotic lipid core features. These double-positive cells were lipid rich and were mostly found close to the necrotic core ( Figure VIIC in the online-only Data Supplement). These histological and immunostaining data are consistent with the results in vitro because VSMC cells that had migrated from the media to this location would be chronically exposed to cholesterol (which would allow uptake through multiple mechanisms over time), 14 likely inducing the expression of CD68. Furthermore, they are consistent with recent data from human plaques that have also demonstrated cells doubly positive for ACTA2 and CD68. 16 Collectively, the multiple lines of evidence in 
Transcription Factor-Binding Site Motif Enrichment Analysis
Despite the lack of the full assumption of the macrophage state with cholesterol loading, the microarray analysis still showed a remarkable number (613) of changes in the VSMC transcriptome.
To identify molecular mechanisms that may underlie these broad changes, we sought transcription factor-binding site sequence patterns (motifs) that were statistically over-represented (Materials and Methods in the online-only Data Supplement). A comparison was made to transcription factor-binding site sequence patterns from a literature-curated database of protein-DNA binding interactions (TRANSFAC; www.biobase-international.com) 27 that are likely to be expressed in VSMC (Materials and Methods in the online-only Data Supplement). As shown in Figure 3A , the analysis implicates SRF and several other transcription factors, such as the sterol regulatory element binding protein (SREBP) family, PPARγ (peroxisome proliferator-activated receptor gamma), NFKB (nuclear factor kappa-light-chain-enhancer of activated B cells), and the krüppel-like family of transcription factors (KLFs), in the response of mouse aortic VSMC to cholesterol loading. Notably, the liver X receptor was not among the transcription factors implicated, despite its upregulation by cholesterol loading in other settings. 28 Because of their central importance in VSMC differentiation, we performed a secondary computational analysis of SRF-binding elements (CArG box elements) using a genomewide database of CArG boxes that are phylogenetically conserved. 29 This more stringent bioinformatic analysis showed statistical over-representation of conserved CArG boxes within the promoters of cholesterol-downregulated genes (P<0.05; Materials and Methods in the online-only Data Supplement), but not within the promoters of cholesterol-upregulated genes. Because of the strength of the SRF-binding site over-representation in the unbiased and secondary analyses, and the general importance of the complex of SRF and myocardin in regulating SM gene transcription, 30, 31 we next focused on functional aspects of these 2 regulators of SM contractile phenotype in cholesterol-loaded VSMC.
Cholesterol Loading Downregulates the Expression of SRF and Myocardin in VSMC
Because cholesterol loading in vitro results in a decrease of VSMC-related gene expression, we tested whether this resulted from reduced Myocd and Srf expression levels. qRT-PCR results shown in Figure 3B demonstrate that, indeed, cholesterol-loaded VSMC have significantly lower levels of Myocd and Srf mRNA, with corresponding changes in the SRF/myocardin-dependent marker calponin (Cnn1). 30, 31 Although cholesterol loading downregulated SRF expression to ≈60% of that in control cells, Myocd mRNA was decreased even more, to ≈23% of control. Consistent with the qRT-PCR results, cholesterol-loaded VSMC were characterized by a lower level of SRF protein ( Figure 3C ). We were unable to measure myocardin protein because of the insensitivity of commercially available antibodies. March 2015
Overexpression of Myocardin Prevents and Reverses the Loss of VSMC Features After Cholesterol Loading
Given the result that cholesterol loading suppresses SRF/myocardin expression and the central importance of these factors to VSMC differentiation, we used Myocd adenoviral transduction (Ad-myocardin) to test whether overexpression of Myocd would prevent VSMC from losing features of their phenotype and gaining those of macrophages. Before cholesterol loading, VSMC were transduced with Ad-myocardin or Ad-Lacz (control) at a multiplicity of infection (moi) of 50, 100, and 300. Immunostaining ( Figure 4A ) showed that Ad-myocardin cells (300 moi) retained the VSMC phenotype with cholesterol loading (ie, they remained ACTA2 + and CD68 -), whereas control Ad-LacZ VSMC became ACTA2 poor and CD68 + . Furthermore, the qRT-PCR data ( Figure 4B and 4C) demonstrate that Ad-myocardin significantly increased Cnn1 and suppressed Cd68 mRNA expression in a dose-dependent manner.
These results suggest that Ad-myocardin transduction can completely (300 moi) or partially (100 moi) block the loss of VSMC features and the induction of CD68 on cholesterol loading.
Next, we tested whether myocardin adenoviral transduction can restore the original VSMC phenotype after cholesterol loading. First, VSMC were loaded with cholesterol for 3 days (as before), then they were transduced with Ad-myocardin or Ad-LacZ overnight. After virus was removed, the cells were kept in fetal bovine serum for 3 days. qRT-PCR results ( Figure 4D and 4E) show that Ad-myocardin increased Cnn1 and Srf mRNA and suppressed Cd68 expression. Thus, myocardin overexpression not only prevents changes in VSMC after cholesterol loading but also restores the original phenotype after these changes occur.
Role of Srebf2 in the Phenotypic Changes in Cholesterol-Loaded VSMC
SREBP-2 (encoded by Srebf2) controls the transcription of sterol-regulated genes. 32 The microarray results showed that, as , and serum response factor (SRF). A, Bars show statistical significance (negative log 10 P value) for over-representation of transcription factor-binding sites within the promoters of the indicated gene set (genes that are cholesterol upregulated or genes that are cholesterol downregulated). Each bar corresponds to a TFBS motif whose occurrences were over-represented (P<0.01) compared with the frequency expected by chance within promoters of genes with altered expression in response to cholesterol loading. Patterned bars indicate motifs whose occurrences are over-represented within the promoters of upregulated genes; open bars correspond to downregulated genes. Vertical scale is negative logarithmic, so increased bar height corresponds to greater statistical significance. SREBP indicates the sterol regulatory element (SRE), which can be bound by either Sterol regulatory element binding protein (SREBP)-1 or SREBP-2. B, VSMC were treated as in Figure 1 , and RNA was harvested for quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) analysis. In cholesterol-loaded VSMC (gray bars), the mRNA abundances of Myocd, Srf, and calponin (Cnn1) decreased significantly compared with the control cells cultured in 0.2% BSA (C). Western blot analysis demonstrates that in cholesterol-loaded VSMC, there is ≈50% reduction in SRF at the protein level compared with control cells (*P<0.05; **P<0.001). Data shown are mean±SD of triplicates of qRT-PCR assays (C) or Western blotting densitometric analysis (D) and are representative of 2 independent experiments. expected, the Srebf2 mRNA level was suppressed in cholesterol-loaded cells (not shown). The finding of enrichment of the SRE within promoters of upregulated genes may reflect differential activation of SREBP isoforms in response to cholesterol loading. 33 It is possible, then, that in addition to SRF/myocardin, SREBP-2 also contributes to the phenotypic changes in cholesterol-loaded VSMC because of the regulation of a critical subset of its target genes. If so, the loss of VSMC characteristics would be preventable by overexpressing SREBP-2.
To test this, VSMC were transduced overnight either with Ad-SREBP-2 or with control Ad-LacZ at moi of 300, then incubated with or without cyclodextrin-cholesterol complexes. As shown in Figure VIII in the online-only Data Supplement, cholesterol loading resulted in downregulation of VSMC marker ACTA2 and upregulation of macrophagerelated gene Mac-2 (Lgals3) to the same degree in all experimental groups. This was despite ≈3× increases (P<0.01) in Srebf2 mRNA with vector treatment (relative to the levels in unloaded control cells), making it unlikely that Srebf2 regulated genes are key participants in the phenotypic changes when VSMC are cholesterol loaded.
Roles of miR-143/145 in VSMC Phenotypic Changes in Response to Cholesterol Loading
Because several recent studies have demonstrated miR-143 and miR-145 work together to regulate myocardin expression and VSMC phenotypic switching, 34 we next focused on the roles of these micro RNAs in the response to cholesterol loading. First, we established that both miR-143 and miR-145 are downregulated in cholesterol-loaded mouse aortic VSMC ( Figure 5A ), consistent with previous reports that their expression is low in the cholesterol-laden aorta of atherosclerotic Apoe −/− mice, especially when plasma hyperlipidemia is even further elevated by a high-fat diet 35, 36 ; also contributing to this could be the infiltration of authentic macrophages, which have comparatively low levels of miR-143/miR-145 expression (≈15% of that in control VSMC; H. Nishi, E. Fisher, unpublished data, 2014).
Next, we used miRNA mimics to test whether restoring their levels ameliorates the effects of cholesterol loading. As shown in Figure 5B , the mRNA level of the VSMC marker CNN1 was significantly higher in cells treated with miR-143/ miR-145 mimics before cholesterol loading when compared with the 2 control groups. The protective effects of the miR-143/miR-145 pretreatment were likely because of their maintenance of myocardin and SRF expression ( Figure 5C and 5D ) in the face of cholesterol loading.
ApoA1 and HDL Reverse Phenotypic Changes Induced by Cholesterol Loading of VSMC
A question of both fundamental and clinical interest is whether the phenotypic changes in VSMC on cholesterol loading can be reversed by unloading, particularly by natural acceptors of cholesterol. To address this, VSMC were treated as before for 72 hours with cyclodextrin-cholesterol complexes, and then incubated for an additional 72 hours with either apoA1 or the control protein, BSA. As shown in Figure 6 , as expected, cholesterol loading reduced and increased the expression of ACTA2 and CD68, respectively, at both the protein and mRNA levels ( Figure 6A and 6C) . After 72 hours of cholesterol efflux mediated by apoA1, however, the typical VSMC appearance and marker expression were restored, and lost was the expression of macrophage markers (Figure 6B and 6C) . Similar results were observed with cholesterol acceptors HDL and cyclodextrin (data not shown), indicating that the effects were because of cholesterol efflux, in general, and not a specific pathway.
Because of the results implicating the miR-143/145 regulatory network ( Figure 5 ) in the molecular response of VSMC to cholesterol loading, we also measured efflux-associated changes in the levels of these micro RNAs and their key target Myocd. As shown in Figure 5D , cholesterol unloading of VSMC by HDL increased the expression of Myocd, miR-143, and miR-145, suggesting that these changes were the mechanistic basis of the phenotypic reversibility ( Figure 5B and 5C ).
Discussion
Although it is commonly assumed that the majority of atherosclerotic plaque foam cells originate from the circulating monocytes recruited into the vessel wall, VSMC can also become lipid-laden in vitro and in vivo. 14, 16 It is also well established that VSMC that migrate from the medial layer into the plaque intima lose expression of many factors related to the contractile phenotype, such as myosin heavy chain and SM cell actin. Recent data from mouse 20, 24 and human plaques 16 confirm that a subset of foam cells originates from VSMC and extend these findings by showing that many of these cells display macrophage markers. Indeed, it is estimated that ≈30% to 40% of foam cells in mouse or human plaques positive for standard macrophage markers, such as CD68 or Mac-2, are of VSMC origin. 16, 20, 24 This would be consistent with our previous report that cholesterol loading of mouse aortic SMC in vitro caused them to rapidly become foam cells, to lose the expression of several contractile VSMC-related markers, and to gain the expression of several macrophage-related markers. 15 That similar observations are now made with human coronary artery SM cells ( Figure I in the online-only Data Supplement) supports the general importance and clinical relevance of the mechanistic findings in the present study.
In the present study, we have focused on the underlying molecular bases for these effects of cholesterol loading on VSMC. On the basis of a variety of bioinformatic and functional approaches applied to primary mouse cells, the major findings are as follows: (1) the master transcription factors that Figure  1 . Images shown are (40×). As expected, the protein level of ACTA2 decreased, whereas that of CD68 increased. B, Next, cholesterol-loaded VSMC were incubated with apoA1 for 72 hours, which restored the typical VSMC appearance and ACTA2 expression, with loss of CD68 expression. C, Consistent with immunostaining, cholesterol-loaded cells had reduced and increased, respectively, Acta2 and Cd68 mRNA levels. D, Cholesterol-loaded VSMC were treated as in C, but HDL was used instead of apoA1. By quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) analysis, there were recoveries of the expression of the VSMC marker Cnn1, as well as of the regulatory factors Myocd and miR-143/145 (*P<0.5 vs control). Data shown are mean±SD of triplicates of qRT-PCR reactions and are representative of 2 independent experiments. control the VSMC contractile phenotype, SRF and myocardin, as well as 2 key microRNAs that, in turn, regulate them, miR-143/145, decrease in expression on cholesterol loading. That these changes are causal is supported by experiments in which maintaining myocardin or miR-143/145 levels either prevents or reverses the effects of cholesterol loading; (2) despite the induced expression of some macrophage markers in cholesterol-loaded VSMC, by PCA the overall transcriptome remains closer to that of VSMC than that of authentic macrophages; (3) consistent with the PCA analysis, cholesterol-loaded VSMC are relatively poor in the macrophage activities of phagocytosis and efferocytosis; and (4) phenotypic changes caused by cholesterol loading can be prevented by the promotion of cholesterol efflux by artificial and natural acceptors.
There are many clinically relevant implications of our results, especially in light of the recent evidence noted above that the phenotypic changes corresponding to what we find in mouse VSMC loaded with cholesterol in vitro occur with frequency in the atheroma of mice and humans. 16, 20, 24 First, the molecular mechanisms in vivo are likely to be similar to what we discovered in vitro, as suggested by the downregulation of miR-143/145 in the aortae of apoE-deficient mice, which becomes even more profound when they are fed a Westerntype diet to exacerbate their hypercholesterolemia. 35, 36 Second, the functional consequences of the changes observed in vitro, if they were to occur in vivo, may be adverse. For example, although the overall transcriptome remained VSMC-centric, there was upregulation of several proatherogenic factors, such as macrophage-specific inflammatory cytokine mRNAs, including Ccl2 and Ccl7, as well as the toll-like receptor Tlr4, consistent with the transcription factor-binding factor analysis that identified over-representation of mRNAs encoded by genes with NF-kβ sites. Furthermore, our finding of cells of VSMC origin with macrophage features that border the necrotic core ( Figure VII in the onlineonly Data Supplement) and likely deficient in efferocytosis ( Figure 2D ; Figure VI in the online-only Data Supplement) suggests that they would inefficiently clear apoptotic cells and consequently contribute to core expansion. 23 That cells in this location would be particularly susceptible to cholesterol loading, and its induction of phenotypic/functional changes is entirely plausible, given the high ambient extracellular cholesterol they are exposed to, some of it in the form of cholesteryl ester-rich inclusions derived from necrotic foam cells, which are avidly taken up by VSMC, 14 and the impairment in ABCA1 expression and function in intima-type arterial SM cells. 7 Another possible consequence of clinical significance could be that the cholesterol loading of VSMC attenuates their ability to elaborate extracellular matrix components that serve to stabilize plaques, as implied by the downregulation of several relevant genes on the microarray (Table III in the onlineonly Data Supplement) .
Third, the reversibility of the effects of cholesterol loading by efflux may contribute to the formation of SMC-containing fibrous caps that we previously observed when mouse plaques were placed into an atherosclerosis regression environment in which HDL was increased. 37, 38 Notably, after the change in the plasma lipoprotein profile, the number of subendothelial cells that were CD68 + decreased and those ACTA2 + increased. Furthermore, the transcriptome profile of CD68 + cells that were laser captured from regressing plaques showed enrichment in the expression of genes associated with the contractile apparatus. 26 If these phenomena represented the restoration in CD68 + VSMC aspects of the ACTA2 + phenotypic state, and similar effects occur in foam cells of VSMC origin in human plaques, then emerging therapies to increase cholesterol efflux clinically by apoA1 or HDL infusions or by anti-miR33 treatment 39 may also promote fibrous cap formation in patients, resulting in stabilization of vulnerable plaques.
Although we have provided data to implicate downregulation of the miR-143/145/SRF/myocardin axis as the molecular mechanism of the loss of the contractile VSMC phenotype, of interest are 2 questions, namely, how cholesterol regulates the regulators of the contractile phenotype and what turns on the macrophage-specific factors. An obvious candidate because of its role in cholesterol regulation of gene expression, 32 SREBP2, turned out not to address either question. Instead, the answers to both questions may involve the transcription factor KLF4. KLF4 is a repressor of SRF/myocardin 40 and itself is repressed by the miR-143/145/SRF/myocardin axis in a complicated feedback loop. 35 Thus, it is expected that KLF4 will increase after cholesterol loading because miR-143/145/SRF/myocardin all become downregulated. In preliminary studies, this is indeed the case; moreover, when myocardin levels are maintained in cholesterol-loaded VSMC, KLF4 expression was suppressed ( Figure IXA in the online-only Data Supplement). The connection between KLF4 and the macrophage marker expression (question 2) comes from studies showing that it is a required factor in monocyte differentiation. 41 Thus, it is tempting to speculate that the increased expression of KLF4 after cholesterol loading participates not only in the loss of the contractile phenotype but also in the assumption of some of the monocyte-macrophage features by cholesterol-loaded VSMC.
Another likely factor in the loss of key phenotypic features of contractile VSMC upon cholesterol loading is transforming growth factor β. Transforming growth factor β is a longestablished promoter of this phenotype of VSMC, at least, in part, by inducing Myocd expression, 42 which we have recently reported is an effect upstream of miR-143/145 43 . Most intriguing, then, is that cholesterol enrichment of cells has been reported to dampen transforming growth factor β signaling. 44 The mechanism is likely related to changes in membrane fluidity or lipid raft characteristics regulated by cholesterol content, which affects a host of receptors, channels, and other membrane-associated proteins. 45 These considerations and our exciting finding in preliminary studies that cholesterolloaded mouse VSMC exhibit attenuation of transforming growth factor β signaling ( Figure IXB in the online-only Data Supplement) support it being a plausible player in the loss of the contractile VSMC phenotype.
It should be noted that in addition to miR-143/145, there is another factor that is a molecular link among SRF, myocardin, and KLF4. Ten-eleven-translocation 2 is a DNA demethylase recently shown to be enriched in contractile VSMC, and its knockdown, similar to cholesterol loading, inhibited expression of SRF and myocardin with concomitant upregulation of KLF4. 46 That ten-eleven-translocation 2 that is potentially relevant to the present results is further supported by the transcription factor-binding site sequence patterns analysis. As shown in Figure 3 , the binding site sequence pattern for EBF1 (early B-cell factor 1), an interaction partner for ten-eleven-translocation 2, 47 was over-represented among the 5′ regulatory regions of VSMC genes that went up in response to cholesterol loading.
Although our results have been discussed mainly with regard to atherosclerosis, it is interesting to consider them in the general context of VSMC differentiation. Unlike terminally differentiated skeletal or cardiac muscle cells, VSMC remain remarkably plastic, 19 with changes in their phenotype occurring in a variety of vascular disorders besides atherosclerosis. 48 A signature feature of such modifications is the reduced expression of VSMC marker genes, such as Myh11, Cnn1, and the master regulator of these contractile genes, Myocd. The novelty of the present findings is that these changes in VSMC can be provoked simply by cholesterol loading. New methods, such as the elegant approach of tracing VSMC lineage in situ using epigenetic marks, 49 will improve the ability to detect phenotypically modified VSMC and better define the circumstances in vivo in which they occur.
In summary, the present results provide strong experimental evidence that cholesterol loading causes changes in VSMC in vitro that result not only in their loss of the contractile phenotype but also in their being mistaken for macrophages. The recent demonstration that up to 40% of human plaque macrophage foam cells are of VSMC origin 16 is entirely consistent with these findings, making it plausible that the mechanism we uncovered in vitro-the downregulation by cholesterol of miR-143 and miR-145, which, in turn, downregulates the myocardin/SRF axis in VSMC of both murine and human origin-is similarly operative in vivo. Furthermore, the reversibility of the changes has implications not only for the understanding of the fundamental biology of plaques but also for the therapeutic approach to their stabilization in patients experiencing, or at risk of, acute coronary syndromes.
We previously showed that cholesterol loading in vitro converts mouse aortic vascular smooth muscle cells from a contractile state to one resembling macrophages. In human and mouse atherosclerotic plaques, it has become appreciated that ≈40% of cells classified as macrophages by histological markers may be of vascular smooth muscle cells origin. The present studies show that cholesterol loading of vascular smooth muscle cells converts them to a macrophage-appearing state by downregulating the miR-143/145-myocardin/SRF axis. Although these cells would be classified as macrophages in human and mouse plaques by immunohistochemistry, their transcriptome and functional properties imply that their contributions to atherogenesis would not be those of classical macrophages, yet they would be considered as such by conventional criteria.
Significance
